Back to Browse Journals » Virus Adaptation and Treatment » Volume 3

A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome

Authors A Martin Lerner, Safedin Beqaj

Published Date February 2011 Volume 2011:3 Pages 19—24

DOI http://dx.doi.org/10.2147/VAAT.S15105

Published 21 February 2011

A Martin Lerner1, Safedin Beqaj2
1Department of Medicine, William Beaumont Hospital, Royal Oak, MI, USA; 2DCL Medical Laboratories, Indianapolis, IN, USA

Abstract: There is no accepted science to relate herpesviruses (Epstein–Barr virus [EBV], human cytomegalovirus [HCMV], and human herpesvirus 6 [HHV6]) as causes of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). ME/CFS patients have elevated serum immunoglobulin (Ig)G serum antibody titers to EBV, HCMV, and HHV6, but there is no herpesvirus DNA-emia, herpesvirus antigenemia, or uniformly elevated IgM serum antibody titers to the complete virions. We propose that herpesvirus EBV, HCMV, and HHV6 immediate-early gene expression in ME/CFS patients leads to host cell dysregulation and host cell apoptosis without lytic herpesvirus replication. Specific antiviral nucleosides, which alleviate ME/CFS, namely valacyclovir for EBV ME/CFS and valganciclovir for HCMV/HHV6 ME/CFS, inhibit herpesvirus DNA polymerases and/or thymidine kinase functions, thus inhibiting lytic virus replication. New host cell recruitment thus ceases. In the absence of new herpesvirus, nonpermissive herpesvirus replication stops, and ME/CFS recovery ensues.

Keywords: ME/CFS, Epstein–Barr virus (EBV), human cytomegalovirus (HCMV), HHV6, abortive replication

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Inertial sensors as measurement tools of elbow range of motion in gerontology

Sacco G, Turpin JM, Marteu A, Sakarovitch C, Teboul B, Boscher L, Brocker P, Robert P, Guerin O

Clinical Interventions in Aging 2015, 10:491-497

Published Date: 23 February 2015

Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients

Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, Zhao T, Zhang Z, Wang C, Sun X, Qiu P

OncoTargets and Therapy 2015, 8:487-493

Published Date: 23 February 2015

Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects

Shodeinde AL, Barton BE

OncoTargets and Therapy 2012, 5:119-125

Published Date: 4 July 2012

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options

Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C

Cancer Management and Research 2012, 4:75-89

Published Date: 12 March 2012

A novel high-throughput analysis approach: immune response-related genes are upregulated in age-related hearing loss

Tra Y, Frisina RD, D'Souza M

Open Access Bioinformatics 2011, 3:107-122

Published Date: 22 August 2011

Acyclovir and hydrocortisone cream for the early treatment of recurrent cold sores

Carrie A Sailer, Spotswood L Spruance, Christopher M Hull

Virus Adaptation and Treatment 2011, 3:1-6

Published Date: 11 January 2011

A regional model of interprofessional education

Maria Olenick, Edward Foote, Patricia Vanston, et al

Advances in Medical Education and Practice 2011, 2:17-23

Published Date: 10 January 2011

A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis

Stephen P Myers, Joan O’Connor, J Helen Fitton, et al.

Biologics: Targets and Therapy 2010, 4:33-44

Published Date: 12 February 2010

Alogliptin: a new addition to the class of DPP-4 inhibitors

Radha Andukuri, Andjela Drincic, Marc Rendell

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:117-126

Published Date: 21 July 2009